The Initiative

The WOLVAX-DENGAFRICA proposal has been officially submitted under the call HORIZON-JU-GH-EDCTP3-2026-02-two-stage Global collaboration action on climate and health in sub-Saharan Africa. The core objective of this initiative is to evaluate innovative strategies to prevent the growing impact of dengue across West Africa.

The Context: A Rising Health Threat

Dengue is increasingly reported throughout sub-Saharan Africa, with repeated epidemics hitting countries such as Burkina Faso, Senegal, and Mali, where the virus has become one of the most frequently detected arboviruses. Despite this growing threat, evidence-based prevention strategies adapted to African settings remain limited, particularly within climate-sensitive transmission contexts.

The Strategy: Vector Control and Vaccination

WOLVAX-DENGAFRICA proposes a pragmatic, climate-informed programme that combines next-generation vector control with targeted vaccination:

  • Vector Control (Côte d’Ivoire): The project will implement a Wolbachia-based vector control strategy targeting Aedes albopictus, an invasive mosquito species responsible for dengue transmission in both Africa and Europe.

  • Clinical Trial (Côte d’Ivoire, Burkina Faso, and Mali): In parallel, a phase 2b clinical trial will evaluate a live attenuated dengue vaccine candidate. This study will focus specifically on safety, immunogenicity, and the feasibility of simplified vaccination schedules, including for vulnerable populations such as individuals with sickle cell disease.

A Strong International Consortium

The project is coordinated by Aix-Marseille Université and brings together a multidisciplinary network of European and African institutions. The consortium unites leading expertise in arbovirology, vaccination, vector control, clinical research, and public health implementation, featuring collaboration among Université de Bordeaux, Institut Pasteur, INSERM, ENEA, Centro Agricoltura e Ambiente Giorgio Nicoli, R-Evolution Worldwide, Institut National de Santé Publique, Association PAC-CI, and Institut Pasteur de Côte d’Ivoire.

Expected Impact

The insights gained from this project are expected to actively support future policy recommendations and significantly strengthen preparedness for dengue emergence in sub-Saharan Africa under rapidly changing climate conditions.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

IMPROVE-HIV proposal submitted to EDCTP3 to address HIV, HBV and schistosomiasis co-infections in sub-Saharan Africa

R-Evolution WorldWide, has recently submitted the project proposal IMPROVE-HIV under the European & Developing Countries Clinical Trials Partnership (EDCTP) call HORIZON-JU-GH-EDCTP3-2026-01-HIV-03-two-stage – Global collaboration action towards better prevention, treatment and clinical management

World Tuberculosis Day – March 24, 2026

Tuberculosis (TB) remains one of the leading infectious diseases worldwide. According to the WHO Global Tuberculosis Report, in 2023 an estimated 10.8 million people developed TB globally, and about 1.25

Second International Conference on Public Health in Africa

  The Second International Conference on Public Health in Africa (CPHIA) was held in Kigali on 13th-15th December 2022. In CPHIA 2022 conference were addressed discussion on need to ensure global health